Quick Comparison
| NMN (Nicotinamide Mononucleotide) | Vitamin D3 | |
|---|---|---|
| Half-Life | 2-3 minutes in blood (rapidly converted to NAD+). NAD+ half-life: 1-2 hours in tissue | 15-25 days |
| Typical Dosage | Standard: 250-1000 mg daily. Sublingual may improve bioavailability by bypassing first-pass metabolism. Take in the morning — NAD+ follows circadian rhythm and morning supplementation aligns with natural peaks. Effects build over weeks. | Standard: 2000-5000 IU daily. Optimal blood level: 40-60 ng/mL (100-150 nmol/L). Most adults need 4000-5000 IU to reach optimal levels. Take with fat for absorption. Get blood levels tested before supplementing — both deficiency and excess are harmful. |
| Administration | Oral (capsules, powder, sublingual). Sublingual may improve bioavailability. Store in cool, dry place. | Oral (softgels, drops, tablets). D3 (cholecalciferol) preferred over D2 (ergocalciferol). Take with a fat-containing meal. |
| Research Papers | 10 papers | 10 papers |
| Categories |
Mechanism of Action
NMN (Nicotinamide Mononucleotide)
NMN is transported into cells via the Slc12a8 transporter (highly expressed in the small intestine and brain) and converted to NAD+ by nicotinamide mononucleotide adenylyltransferases (NMNAT1 in the nucleus, NMNAT2 in axons/Golgi, NMNAT3 in mitochondria). Elevated NAD+ activates the sirtuin family of NAD+-dependent protein deacetylases: SIRT1 deacetylates PGC-1alpha to promote mitochondrial biogenesis, SIRT3 activates superoxide dismutase 2 (SOD2) and isocitrate dehydrogenase 2 (IDH2) for mitochondrial antioxidant defense, and SIRT6 promotes base excision repair of oxidative DNA damage. NAD+ is also consumed by poly(ADP-ribose) polymerases (PARP1/2) during DNA repair — age-related NAD+ depletion impairs PARP function, allowing DNA damage accumulation. In neurons, NAD+ is required for glycolysis (GAPDH cofactor), the TCA cycle, and Complex I of the electron transport chain, directly fueling the enormous ATP demands of synaptic transmission. NAD+ decline with aging (approximately 50% reduction between ages 40-60) reduces all of these processes simultaneously, creating a cascade of mitochondrial dysfunction, impaired DNA repair, and neuroinflammation that NMN supplementation aims to reverse.
Vitamin D3
Vitamin D (1,25-dihydroxyvitamin D3) crosses the blood-brain barrier and binds to vitamin D receptors (VDR), a nuclear receptor expressed on neurons, astrocytes, microglia, and oligodendrocytes. VDR heterodimerizes with RXR and binds vitamin D response elements (VDREs) to regulate transcription. It upregulates neurotrophic factors: GDNF (glial cell line-derived), NGF, NT-3 via CREB and other transcription factors. Vitamin D promotes serotonin synthesis by upregulating tryptophan hydroxylase 2 (TPH2) and dopamine synthesis via tyrosine hydroxylase. It reduces neuroinflammation by suppressing microglial IL-1beta, TNF-alpha, and iNOS, and supports calcium homeostasis via regulation of L-type voltage-gated calcium channels and calbindin-D28k. Vitamin D regulates over 200 genes including those for neuroprotection, synaptic plasticity, and myelination.
Risks & Safety
NMN (Nicotinamide Mononucleotide)
Common
Mild flushing, nausea, headache initially.
Serious
Long-term human safety data still limited (first human trials completed 2020-2023). Theoretical concern about promoting cancer growth in existing tumors (NAD+ fuels fast-growing cells).
Rare
Insomnia if taken late.
Vitamin D3
Common
Generally very safe at standard doses.
Serious
Toxicity at very high doses (>10,000 IU daily for months) — causes hypercalcemia (nausea, kidney stones, cardiac arrhythmia).
Rare
Headache, metallic taste, nausea.
Full Profiles
NMN (Nicotinamide Mononucleotide) →
A direct precursor to NAD+ (nicotinamide adenine dinucleotide), a coenzyme essential for cellular energy production, DNA repair, and sirtuin activation. NAD+ levels decline 50% between ages 40 and 60, contributing to age-related cognitive decline and neurodegeneration. NMN supplementation restores NAD+ levels and improves mitochondrial function, memory, and neuroplasticity in animal models.
Vitamin D3 →
Technically a hormone, not a vitamin. Vitamin D3 (cholecalciferol) receptors are found throughout the brain, particularly in the hippocampus and prefrontal cortex. Deficiency — affecting an estimated 40-75% of adults worldwide — is associated with cognitive impairment, depression, and increased Alzheimer's risk. Supplementation is one of the most impactful interventions for people with low levels.